• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汉族人群中的遗传性乳腺癌。

Hereditary breast cancer in the Han Chinese population.

机构信息

Institute of Cell Biology, Zhejiang University, Hangzhou, China.

出版信息

J Epidemiol. 2013;23(2):75-84. doi: 10.2188/jea.je20120043. Epub 2013 Jan 12.

DOI:10.2188/jea.je20120043
PMID:23318652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3700245/
Abstract

Breast cancer is the most common malignancy among women and has a strong genetic background. So far, 13 breast cancer susceptibility genes of high or moderate penetrance have been identified. This review summarizes findings on these genes in Han Chinese. BRCA1 and BRCA2 are the 2 most important susceptibility genes. They have a relatively low mutation rate, and the most frequent sites of mutation are in exon 11. Frameshift mutations are the main type of mutation. Founder mutations may also exist, and BRCA-associated breast cancer has specific clinicopathologic characteristics. TP53 and PALB2 are relatively rare susceptibility genes. The relationship between the other 9 genes and breast cancer has not been fully elucidated. At present, the mutation spectrum for these susceptibility genes is not well understood in the Chinese population, and there are few reports on prognosis and clinical intervention in high-risk populations. Therefore, the true value of genetic counseling for breast cancer has yet to be realized. This article reviews studies of hereditary breast cancer in the Han Chinese population, highlights potential inadequacies, and provides a foundation for genetic counseling for breast cancer in China.

摘要

乳腺癌是女性中最常见的恶性肿瘤,具有很强的遗传背景。迄今为止,已经确定了 13 个具有高或中等外显率的乳腺癌易感基因。本综述总结了这些基因在汉族人群中的研究发现。BRCA1 和 BRCA2 是 2 个最重要的易感基因。它们的突变率相对较低,最常见的突变部位在第 11 外显子。移码突变是主要的突变类型。也可能存在种系突变,BRCA 相关乳腺癌具有特定的临床病理特征。TP53 和 PALB2 是相对罕见的易感基因。其他 9 个基因与乳腺癌的关系尚未完全阐明。目前,中国人群对这些易感基因的突变谱了解甚少,也很少有关于高危人群预后和临床干预的报道。因此,遗传咨询在乳腺癌中的真正价值尚未得到体现。本文综述了汉族遗传性乳腺癌的研究,突出了潜在的不足,为中国的乳腺癌遗传咨询提供了基础。

相似文献

1
Hereditary breast cancer in the Han Chinese population.汉族人群中的遗传性乳腺癌。
J Epidemiol. 2013;23(2):75-84. doi: 10.2188/jea.je20120043. Epub 2013 Jan 12.
2
Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.通过二代测序技术鉴定中国人群遗传性乳腺癌的综合遗传因素谱。
PLoS One. 2015 Apr 30;10(4):e0125571. doi: 10.1371/journal.pone.0125571. eCollection 2015.
3
Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.采用基因测序和高分辨率 DNA 熔解分析鉴定中国南方乳腺癌患者中的 BRCA1/2 种系突变。
PLoS One. 2012;7(9):e43994. doi: 10.1371/journal.pone.0043994. Epub 2012 Sep 7.
4
Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.通过下一代测序分析中国未选择乳腺癌患者的BRCA1/2突变谱及发生率
J Cancer Res Clin Oncol. 2017 Oct;143(10):2011-2024. doi: 10.1007/s00432-017-2465-8. Epub 2017 Jun 29.
5
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.在高危芬兰 BRCA1/2 种系突变阴性的乳腺癌和/或卵巢癌个体中筛查 BRCA1、BRCA2、CHEK2、PALB2、BRIP1、RAD50 和 CDH1 突变。
Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.
6
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.中国大陆家族性乳腺癌和卵巢癌患者中BRCA种系变异的患病率及谱系
Oncotarget. 2016 Feb 23;7(8):9600-12. doi: 10.18632/oncotarget.7144.
7
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.中国高遗传风险乳腺癌患者中 40 个癌症易感性基因的种系突变。
Int J Cancer. 2019 Jan 15;144(2):281-289. doi: 10.1002/ijc.31601. Epub 2018 Nov 8.
8
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.中美洲和南美洲人群中BRCA1、BRCA2及其他乳腺癌和卵巢癌易感基因的突变
Biol Res. 2017 Oct 6;50(1):35. doi: 10.1186/s40659-017-0139-2.
9
Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.重新访视那些先前使用12基因检测 panel检测BRCA突变呈阴性的乳腺癌患者。
Breast Cancer Res Treat. 2017 Jan;161(1):135-142. doi: 10.1007/s10549-016-4038-y. Epub 2016 Oct 31.
10
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.印度乳腺癌患者中乳腺癌易感基因BRCA1、BRCA2和p53基因的新型种系突变。
Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8.

引用本文的文献

1
Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review.三阴性乳腺癌中BRCA2基因第27外显子种系突变导致的多药耐药:1例报告及文献复习
Front Oncol. 2025 Jun 19;15:1602870. doi: 10.3389/fonc.2025.1602870. eCollection 2025.
2
Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients -A retrospective study.内分泌治疗与化疗作为转移性luminal HER2阴性乳腺癌患者不同全身治疗模式的比较——一项回顾性研究
Front Oncol. 2022 Jul 26;12:873570. doi: 10.3389/fonc.2022.873570. eCollection 2022.
3
Development and Validation of a New Multiparametric Random Survival Forest Predictive Model for Breast Cancer Recurrence with a Potential Benefit to Individual Outcomes.一种用于乳腺癌复发的新型多参数随机生存森林预测模型的开发与验证,对个体预后可能有益。
Cancer Manag Res. 2022 Mar 1;14:909-923. doi: 10.2147/CMAR.S346871. eCollection 2022.
4
Study on the differences of opinions and choices of high-risk breast cancer populations in China before and after genetic testing.中国高危乳腺癌人群基因检测前后意见及选择差异的研究
Transl Cancer Res. 2019 Dec;8(8):2893-2905. doi: 10.21037/tcr.2019.11.43.
5
mutation spectrum in Chinese early-onset breast cancer.中国早发性乳腺癌的突变谱
Transl Cancer Res. 2019 Apr;8(2):483-490. doi: 10.21037/tcr.2019.03.02.
6
Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.882 例中国 HBOC 高危个体中遗传性乳腺癌和卵巢癌(HBOC)易感性基因突变的流行率。
Cancer Sci. 2020 Feb;111(2):647-657. doi: 10.1111/cas.14242. Epub 2019 Dec 31.
7
Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.全面检测 BRCA1/2 基因突变揭示大片段基因重排与中国遗传性乳腺癌和卵巢癌相关。
BMC Cancer. 2019 Jun 7;19(1):551. doi: 10.1186/s12885-019-5765-3.
8
Deleterious Mutations in DNA Repair Gene Exist in -Negative Chinese Familial Breast and/or Ovarian Cancer Patients.DNA修复基因中的有害突变存在于三阴型中国家族性乳腺癌和/或卵巢癌患者中。
Front Oncol. 2019 Mar 22;9:169. doi: 10.3389/fonc.2019.00169. eCollection 2019.
9
Risk prediction for breast Cancer in Han Chinese women based on a cause-specific Hazard model.基于特定病因风险模型的汉族女性乳腺癌风险预测。
BMC Cancer. 2019 Feb 7;19(1):128. doi: 10.1186/s12885-019-5321-1.
10
Clinicopathologic Factors Related to the Histological Tumor Grade of Breast Cancer in Western China: An Epidemiological Multicenter Study of 8619 Female Patients.中国西部乳腺癌组织学肿瘤分级相关的临床病理因素:一项对8619名女性患者的多中心流行病学研究
Transl Oncol. 2018 Aug;11(4):1023-1033. doi: 10.1016/j.tranon.2018.06.005. Epub 2018 Jul 3.

本文引用的文献

1
RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.RAD50 和 NBS1 不太可能是中国非 BRCA1/2 遗传性乳腺癌的易感基因。
Breast Cancer Res Treat. 2012 May;133(1):111-6. doi: 10.1007/s10549-011-1700-2. Epub 2011 Aug 3.
2
A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women.一个 CHEK2 p.H371Y 突变的反复出现与中国女性的乳腺癌风险相关。
Hum Mutat. 2011 Sep;32(9):1000-3. doi: 10.1002/humu.21538. Epub 2011 Jun 30.
3
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.中国家族性乳腺癌女性中 BRCA1 和 BRCA2 种系突变的流行情况和特征。
Breast Cancer Res Treat. 2012 Apr;132(2):421-8. doi: 10.1007/s10549-011-1596-x. Epub 2011 May 26.
4
A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer.一名中国早发性乳腺癌女性中存在一种新型 BRCA1 种系突变。
Fam Cancer. 2011 Jun;10(2):233-7. doi: 10.1007/s10689-011-9429-y.
5
Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.中国北方汉族人群中 TGFB1 rs1982073 C 等位基因和 FGFR2 rs1219648 G 等位基因携带者罹患侵袭性乳腺癌的风险。
Breast Cancer Res Treat. 2011 Jan;125(2):575-82. doi: 10.1007/s10549-010-1032-7. Epub 2010 Jul 17.
6
Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families.马来西亚高风险乳腺癌-卵巢癌家族中的大 BRCA1 和 BRCA2 基因组重排。
Breast Cancer Res Treat. 2010 Nov;124(2):579-84. doi: 10.1007/s10549-010-1018-5. Epub 2010 Jul 9.
7
Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.中国BRCA相关乳腺癌患者的临床和病理特征
Hugo J. 2009 Dec;3(1-4):63-76. doi: 10.1007/s11568-010-9136-z. Epub 2010 Apr 10.
8
Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population.在中国汉族人群中,BRCA1/BRCA2与ATM/ATR之间的相互作用与乳腺癌易感性相关。
Cancer Genet Cytogenet. 2010 Jul 1;200(1):40-6. doi: 10.1016/j.cancergencyto.2010.03.006.
9
Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women.中国女性乳腺癌风险评估和分层的遗传和临床预测因素。
J Natl Cancer Inst. 2010 Jul 7;102(13):972-81. doi: 10.1093/jnci/djq170. Epub 2010 May 18.
10
A BRCA1 promoter variant (rs11655505) and breast cancer risk.BRCA1 启动子变异(rs11655505)与乳腺癌风险。
J Med Genet. 2010 Apr;47(4):268-70. doi: 10.1136/jmg.2009.073544.